IN150 > (Ibandronate sodium 150 mg (base))

Pill imprint IN150 > has been identified as Ibandronate sodium 150 mg (base).

Ibandronate is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Ibandronate sodium

Imprint:

IN150 >

Strength:

150 mg (base)

Color:

White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Bisphosphonates

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Laboratories, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.